Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 131 Leukemia 59 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Leukemia, Myelomonocytic, Acute 24 Leukemia, Monocytic, Acute 23 Leukemia, Erythroblastic, Acute 21 Leukemia, Megakaryoblastic, Acute 20 Myelodysplastic Syndromes 19 Congenital Abnormalities 18 Leukemia, Promyelocytic, Acute 11 Leukemia, Myelomonocytic, Chronic 10 Anemia, Refractory, with Excess of Blasts 10 Recurrence 8 Myeloproliferative Disorders 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Eosinophilic, Acute 6 Leukemia, Biphenotypic, Acute 6 Lymphoma 5 Leukemia, Basophilic, Acute 5 Carcinoma, Hepatocellular 5 Neoplasm, Residual 4 Multiple Myeloma 4 Blast Crisis 4 Neutropenia 3 Neoplasms, Plasma Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myeloid, Accelerated Phase 3 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2

Interventions

Doxorubicin 120 Ifosfamide 70 Radiotherapy 65 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Trabectedin 36 pazopanib 34 Docetaxel 34 Etoposide 33 pembrolizumab 32 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Surgical Procedures, Operative 18 Radiation 18 Temozolomide 17 Mesna 16 Melphalan 16 Biopsy 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Drug Therapy 15 Dactinomycin 15 Blood Specimen Collection 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡